U.S. Oil and Gas Stock News

Domino's Pizza (DPZ) kicked off Q1 2026 with investors watching how its recent Q4 2025 revenue of US$1.5b and basic EPS of US$5.35 stack up against last year's Q4 2024 figures of US$1.4b in revenue and EPS of US$4.89. Over the past year, the company has seen quarterly revenue move from US$1.1b in Q1 2025 to US$1.5b in Q4 2025, while basic EPS ranged from US$3.84 to US$5.35. This sets the stage for a results season where margin quality and consistency matter as much as headline growth. See our...

Norwood Financial’s latest earnings in focus Norwood Financial (NWFL) opened 2026 with Q1 results that sit on top of a turnaround year, coming off Q4 2025 revenue of US$23.0 million and net income of US$7.4 million, equal to EPS of US$0.81, after a loss in Q4 2024 when revenue was US$2.6 million and net income was US$12.7 million in the red with EPS of US$1.54 in the red. Over the past few reported quarters, revenue has moved from US$16.9 million in Q3 2024 to US$19.4 million in Q1 2025 and...

On April 22, 2026, Goosehead Insurance, Inc. reported Q1 2026 results showing higher revenue and net income year over year, while simultaneously promoting Mark Jones, Jr. to President and Chief Operating Officer and appointing John Martin as Chief Financial Officer. The company also completed a substantial share repurchase program, retiring about 8.02% of its stock for US$131.51 million, which may affect future per-share metrics and capital allocation flexibility. We’ll now examine how...

Verizon Communications (VZ) has just wrapped up Q1 2026 with its recent numbers anchored by Q4 2025 results, where revenue came in at US$36.4b and basic EPS was US$0.55 on net income of US$2,342m. Over the past few quarters, revenue has moved from US$33.5b in Q1 2025 to US$36.4b in Q4 2025, while basic EPS over that stretch ranged between US$0.55 and US$1.18. This gives investors a clear view of how the top line and per share earnings have tracked into this latest update. With trailing net...

Lakeland Financial (LKFN) opened 2026 with Q1 results that sit against a trailing twelve month backdrop of US$257.2 million in revenue and basic EPS of US$4.02, supported by net income of US$103.4 million over that period. Over recent quarters, revenue has moved from US$58.1 million in Q3 2024 to US$60.9 million in Q4 2024 and US$69.8 million in Q4 2025, while quarterly basic EPS has ranged from US$0.91 in Q3 2024 to US$0.94 in Q4 2024 and US$1.17 in Q4 2025. This gives investors a clearer...

Upcoming earnings report puts focus on Kirby’s mixed expectations Kirby (KEX) heads into its upcoming quarterly earnings report with Wall Street expecting higher revenue and earnings, while recent analyst estimate revisions point to more cautious sentiment around the company’s near term profit potential. See our latest analysis for Kirby. Recent price action has been strong, with a 36.18% year to date share price return and a 59.09% total shareholder return over the past year. This suggests...

Bank of Marin Bancorp (BMRC) has just put Q1 2026 in context with a recent quarter that included total revenue of about US$28.5 million and a basic EPS loss of US$2.24, alongside trailing twelve month figures that still reflect unprofitable results. Over recent periods, the company has seen quarterly revenue move from US$24.9 million in Q4 2024 to US$27.7 million in Q1 2025 and US$30.9 million in Q3 2025. Basic EPS has swung between a profit of US$0.62 and a loss of US$2.49, setting up a...

In April 2026, Waterschap Aa en Maas in the Netherlands and Northern Ireland Water selected Tetra Tech to deliver multi-year engineering, consulting, and high-end sampling services to modernize wastewater treatment, safeguard water quality, and enhance flood resilience across their regions. These wins highlight growing international uptake of Tetra Tech’s advanced data analytics and water management software, reinforcing its role in complex, regulated water infrastructure projects across...

Easterly Government Properties (DEA) opened Q1 2026 with trailing twelve month revenue of US$342.9 million and EPS of US$0.27, set against a net profit margin of 3.6% versus 6.2% a year earlier. Over recent quarters the company has seen revenue move from US$308.1 million and EPS of US$0.46 in Q4 2024 to US$342.9 million and EPS of US$0.27 in Q4 2025. Trailing earnings have been described as showing negative growth of 7.5% annually over five years, and analysts embed forecasts of about 4%...

Before weighing up whether CrowdStrike Holdings is attractively priced, you probably want to know if the current share price reflects the business you are actually buying or if expectations have run ahead of fundamentals. CrowdStrike's stock has been active recently, with the last close at US$454.61 after returns of 5.0% over 7 days, 23.0% over 30 days, 0.2% year to date, 7.5% over 1 year, 282.7% over 3 years and 121.6% over 5 years. This performance can influence how the market views both...

What Jade Biosciences’ Recent Move Means For Investors Jade Biosciences (JBIO) has caught investor attention after a sharp share price move over the past month, prompting a closer look at how its current fundamentals and recent trading performance line up. See our latest analysis for Jade Biosciences. At a share price of US$24.98, Jade Biosciences has seen momentum build, with a 7 day share price return of 6.3%, a 30 day share price return of 86.6% and a year to date share price return of...

In April 2026, InMode Ltd. reaffirmed its revenue guidance, projecting US$81.5 million to US$81.7 million for first-quarter 2026 and US$365 million to US$375 million for full-year 2026. This confirmation of management’s outlook underscores the company’s confidence in its current operating trajectory and demand visibility across its aesthetic medical device portfolio. Now we’ll examine how reaffirmed 2026 revenue guidance might influence InMode’s investment narrative built around growth,...

Event driven snapshot of MGIC Investment With no specific headline event setting the tone today, MGIC Investment (MTG) continues to trade around recent levels. This invites investors to reassess how its current share price lines up with its fundamentals and past returns. See our latest analysis for MGIC Investment. Recent trading has been shaped more by a steady grind higher than by sharp moves. A 30 day share price return of 11.31% and a 90 day gain of 8.08% sit alongside a year to date...

Carlisle Companies reported past first-quarter 2026 results with sales of US$1,052.1 million and net income of US$127.7 million, both slightly lower than a year earlier, while earnings per share were broadly stable. Despite weaker revenue, Carlisle expanded margins, reaffirmed its 2026 guidance for low single-digit revenue growth, and continued sizable share repurchases, including 700,000 shares bought back in the quarter. Next, we will examine how Carlisle’s margin expansion amid softer...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Belite Bio (BLTE) has begun a rolling New Drug Application submission to the U.S. Food and Drug Administration for tinlarebant, its oral therapy candidate for Stargardt disease type 1. This marks a key late stage regulatory step. See our latest analysis for Belite Bio. Despite the recent NDA progress and upcoming conference appearances, Belite Bio’s share price return over the past week and quarter has been slightly negative. Its 1 year total shareholder return is very large and its 3 year...

Pharvaris (NasdaqGS:PHVS) is back in focus after new conference data supported the safety of combining its deucrictibant extended release tablet for prophylaxis with immediate release capsules for treating hereditary angioedema breakthrough attacks. See our latest analysis for Pharvaris. The latest conference data seems to have kept interest in Pharvaris alive, with a 1-year total shareholder return of 67.82% and a 3-year total shareholder return above 2x. At the same time, the 90-day share...

Over the last 7 days, the United States market has remained flat, yet it has experienced a significant 30% increase over the past year with earnings projected to grow by 16% annually. In this environment, identifying stocks that may be trading below their estimated fair value can present opportunities for investors seeking potential long-term gains.

The United States market remained flat over the last week, yet it has experienced a 30% rise over the past 12 months with earnings forecasted to grow by 16% annually. In this context of robust growth potential, identifying high-growth tech stocks involves focusing on companies that demonstrate strong innovation and adaptability to capitalize on emerging opportunities.

Over the last 7 days, the United States market has remained flat, though it has risen 30% in the past year with earnings forecasted to grow by 16% annually. In light of these conditions, identifying stocks with strong financials and growth potential can be particularly rewarding. While the term "penny stocks" may seem outdated, it continues to represent smaller or newer companies that offer unique opportunities for investors willing to explore beyond traditional options.

In the last week, the United States market has stayed flat, yet it is up 30% over the past year with earnings forecast to grow by 16% annually. In this environment, growth companies with high insider ownership can be particularly appealing as they often reflect management's confidence in their business prospects and alignment with shareholder interests.

Over the last seven days, the United States market has remained flat, yet it has seen a remarkable 30% rise over the past year with earnings projected to grow by 16% annually in the coming years. In this environment, identifying stocks that are not only poised for growth but also remain underappreciated can offer unique opportunities for investors seeking to capitalize on these favorable conditions.

Over the last 7 days, the United States market has remained flat, yet it has seen an impressive 30% increase over the past year with earnings forecasted to grow by 16% annually. In such a dynamic environment, dividend stocks that offer consistent payouts and potential for growth can be appealing options for investors seeking to balance income and capital appreciation.

In the first quarter of 2026, Globe Life Inc. reported revenue of US$1,559.62 million and net income of US$270.53 million, raised its full-year 2026 earnings guidance to US$15.40–US$15.90 per share, and repurchased 1,400,000 shares for US$203 million. Beyond the headline results, the company highlighted strong growth in health premium revenue, AI-driven efficiency initiatives, and increased capital returns through dividends and buybacks, underlining management’s focus on combining operating...